Latest News

Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study




Callender, T; Emberton, M; Morris, S; Eeles, R; Kote-Jarai, Z; Pharoah, PDP; Pashayan, N; (2019) Polygenic risk-tailored screening for prostate cancer: A benefit-harm and cost-effectiveness modelling study. PLOS Medicine , 16 (12) , Article e1002998. 10.1371/journal.pmed.1002998 . Green open access

Source link





Related posts

'Don’t wash your raw chicken', warns CDC

Newsemia

American Academy Of Dermatology launches new and improved website

Newsemia

World First: Man Controls Two Powered Prosthetic Arms with His Mind

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy